A191 NONALCOHOLIC FATTY LIVER DISEASE AND LIVER FIBROSIS INCREASE CARDIOVASCULAR RISK IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

por Kablawi, D, Aljohani, F, Palumbo, C S, Restellini, S, Bitton, A, Wild, G, Afif, W, Lakatos, P L, Bessissow, T, Sebastiani, G
Publicado 2023

A34 NONALCOHOLIC FATTY LIVER DISEASE AND LIVER FIBROSIS INCREASE CARDIOVASCULAR RISK IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

por Kablawi, D, Aljohani, F, Palumbo, C S, Restellini, S, Bitton, A, Wild, G, Afif, W, Latakos, P L, Bessissow, T, Sebastiani, G
Publicado 2023

A43 SEX DIFFERENCES IN THE ASSOCIATION OF HIV WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD)

por Kablawi, D, Tadjo, T F, Milic, J, Elgretli, W, Gioè, C, Lebouché, B, Cascio, A, Guraldo, G, Mazzola, G, Sebastiani, G
Publicado 2023

A79 THE RELATIONSHIP BETWEEN VISCERAL ADIPOSITY AND NONALCOHOLIC FATTY LIVER DISEASE DIAGNOSED BY CONTROLLED ATTENUATION PARAMETER IN PEOPLE WITH HIV: A PILOT STUDY

por Elgretli, W, Paisible, N, Costiniuk, C, Cox, J, Kablawi, D, Klein, M, Kronfli, N, Routy, J -P, Falutz, J, Lebouche, B, Guaraldi, G, Sebastiani, G
Publicado 2023